Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03029806 · ClinicalTrials.gov registry record · NA
Lysine-specific Demethylase 1 and Salt-sensitivity in Humans
A NA study of Healthy Subjects, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT03029806: Active NA study of Healthy Subjects, sponsored by Brigham and Women's Hospital.
NCT03029806 is a NA study of Healthy Subjects that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 88 participants, below the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03029806, a NA study of Healthy Subjects, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the role dietary salt plays in epigenetic regulation of blood pressure, focusing on the salt-sensitive regulatory enzyme Lysine-specific demethylase 1.
Primary Outcome
Change in aldosterone, baseline to after angiotensin II by genotype/race
Conditions Studied
Interventions
- OTHER Aldosterone response to AngII LS
- OTHER Renal blood flow response to salt
- OTHER Vascular Stiffness
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2017-01-02 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What the registry record for NCT03029806 still lists
NCT03029806 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target (31% lower).
The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 3 interventions - of which Aldosterone response to AngII LS is the first listed.
NCT03029806 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03029806 about?
NCT03029806 is a clinical study titled "Lysine-specific Demethylase 1 and Salt-sensitivity in Humans". The purpose of this study is to investigate the role dietary salt plays in epigenetic regulation of blood pressure, focusing on the salt-sensitive regulatory enzyme Lysine-specific demethylase 1.
What is the current status of trial NCT03029806?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2017-01-02. Estimated completion is 2026-06-01.
What conditions does trial NCT03029806 study?
This clinical trial studies the following conditions: Healthy Subjects.
What interventions are being tested in trial NCT03029806?
The interventions under investigation include: Aldosterone response to AngII LS (OTHER), Renal blood flow response to salt (OTHER), Vascular Stiffness (OTHER).
Who is sponsoring clinical trial NCT03029806?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03029806 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03029806's enrollment target sits among peer trials
88 16th of 69 higher than 54 of 69 other Healthy Subjects trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Subjects trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Ultrasound-induced Anti-inflammation in Human Subjects
RECRUITING · NA
-
The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder
RECRUITING · NA
-
Echography Study_Anthropometric Measurements
RECRUITING · NA
-
Avocado and Postprandial Responses
RECRUITING · NA
-
Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter
RECRUITING · NA
-
In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI